ARA-290

ARA-290 (also known as Cibinetide) is a synthetic peptide derived from the B-helix region of erythropoietin (EPO). Unlike erythropoietin itself, ARA-290 is designed to selectively interact with the Innate Repair Receptor (IRR) pathway without stimulating erythropoiesis. Because of this distinction, it has become an area of interest in laboratory research exploring cellular protection, inflammation modulation, and tissue repair signaling.

In preclinical and early clinical research settings, ARA-290 has been investigated for its potential role in immune signaling pathways, nerve tissue response, and inflammatory cascade modulation. Researchers are particularly interested in how activation of the innate repair receptor may influence cellular recovery mechanisms following stress or injury.

Scientific investigation has explored ARA-290 within several research models, including studies related to neurological signaling, metabolic inflammation pathways, and tissue recovery processes.

Current research areas involving ARA-290 include:

Due to these unique characteristics, ARA-290 continues to be examined in research focused on inflammation signaling, neurological pathways, and regenerative biology.

Product Information

Important Research Notice

This product is intended for laboratory research purposes only.

ARA-290 is not approved by the FDA for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any disease. Products offered by Genora Peptides are supplied strictly for in-vitro laboratory research conducted by qualified professionals

⚠️ For Research Purposes Only: This product is intended for laboratory research use only. Not for human or animal consumption.